QQQ Still Outperforming IBB and XBI in Vicious Sell-Off
Weakness in tools such as ILMN ($59.30) down 15% is hurting biotech. Also our mid cap biopharma index is down 2.5% . So the NASDAQ-100 is favored due to the inclusion of AAPL, AMZN, INTC and MSFT etc and larger cap biotech...
QQQ Trade Beats Biotech ETF’s after One Week
Last week we recommended that bulls trade the QQQ rather than pure biotech with ETF's such as IBB. The strategy was based on the outperformance of biotech compared to tech given that the Q's also have several large cap biotech stocks. Moreover with IBM and AAPL showing great earnings and price...
Biotech Profit Taking Picks Up: MO Stocks Take A Hit-Caution
The Rayno Life Science Portfolio was down 1.76% today which in itself is not alarming but given the weekly volatility against a back-drop of macro issues it is time to avoid complacency. Let's start with the MO players who are those investors with more money than reason but nonetheless have...
Debt Negotiations Stall Market;Gold Up $15 at $1615
Note: we will return from vacation this week and focus on companies attending the AACC (American Association of Clinical Chemistry)Meeting in Atlanta this week). Market Down 0.5% as Both Parties Struggle to Come up with Debt Ceiling Plan One half hour into trading the market has cut losses in...
Surprise Rally Takes Everything Up:Technology OutPerforms Biotechnology
Life Science Stocks Follow NASDAQ Up: EXAS, MITI, REGN Soar Large healthcare companies report over next two weeks Stocks roared today on IBM earnings last night, debt ceiling negotiation progress with bipartisan Senators,and surge in housing starts. AAPL piled on after hours with a huge beat on...